Neurocrine Biosciences Inc (NBIX)

Exchange
NASDAQ
Symbol
NBIX
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric diseases and disorders in the United States. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    124.10
  • High
    126.48
  • Low
    122.47
  • Close
    125.30
  • Volume
    1,214,670

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
24.26
Receivables turnover
4.29
Payables turnover
—
Working capital turnover
1.98
Days of inventory on hand (DOH)
15.05
Days of sales outstanding (DSO)
85.16
Number of days of payables
—
Fixed asset turnover
26.59
Total asset turnover
0.58
 Liquidity ratios
Current ratio
2.45
Quick ratio
2.25
Cash ratio
1.58
Cash conversion cycle
100.21
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.46
Interest coverage
73.20
 Profitability ratios
Gross profit margin
50.66%
Operating profit margin
13.33%
Pretax margin
17.64%
Net profit margin
13.26%
Operating return on assets (Operating ROA)
7.72%
Return on assets (ROA)
7.68%
Return on total capital
15.09%
Return on equity (ROE)
11.19%